|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
|
|---|---|---|---|---|---|
| Collaboration revenue | |||||
| License and milestone | |||||
| Other revenue | |||||
| Total collaboration revenue | |||||
| Expenses | |||||
| Research and development | |||||
| Reacquired license rights | |||||
| General and administrative | |||||
| Depreciation | |||||
| Total expenses | |||||
| Investment income | |||||
| Interest expense | |||||
| Loss on extinguishment of debt | |||||
| Other income (expense) | |||||
| Other income (expense), net | |||||
| Loss before taxes on income | |||||
| Benefit from taxes on income | |||||
| Net loss | |||||
| Net loss per share — basic | |||||
| Net loss per share — diluted | |||||
| Weighted-average number of common shares used in net loss per share — basic | |||||
| Weighted-average number of common shares used in net loss per share — diluted |
Loading...
